DGAP-Adhoc: LANXESS Aktiengesellschaft: Change of

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Feb 26, 2014 at 4:45 AM

DGAP-Adhoc: LANXESS Aktiengesellschaft: Change of competitive environment leads to impairment of EUR 257 million in fourth quarter 2013; FY 2013 net income therefore negative; Planned dividend of EUR 0.50 per share

LANXESS Aktiengesellschaft / Key word(s): Preliminary Results/Dividend 26.02.2014 10:38 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Change of competitive environment leads to impairment of EUR 257 million in fourth quarter 2013; FY 2013 net income therefore negative; Planned dividend of EUR 0.50 per share Cologne - Specialty chemicals company LANXESS has undergone impairment tests, according to IAS 36, that result in exceptional charges of EUR 257 million in the fourth quarter of 2013. Due to the expected development of overcapacities, as well as raw material and energy costs, a competitive environment is anticipated in which future cash flow contributions no longer reflect the book values of the business units Keltan Elastomers and High Performance Elastomers (Performance Polymers segment), as well as Rubber Chemicals (Performance Chemicals segment). The impairment charges are being incurred financially in the fourth quarter of 2013 and affect EBIT and net income in 2013. They are, however, not cash relevant. The above-mentioned impairment charges, together with exceptional expenses of around EUR 30 million, brought forward within the "Advance" efficiency program, result in a negative net income and earnings per share (EPS) in the fourth quarter of 2013, as well as full year 2013. The full-year net loss for 2013 is expected to be EUR 159 million. Full-year EPS is expected to be negative at EUR 1.91. EBITDA pre exceptionals is not subject to the impairment charges and is expected to be EUR 735 million, within the guided range of EUR 710-760 million. The final numbers will be provided in the 2013 consolidated financial statements that have not yet been completed. Subject to Supervisory Board approval, the Board of Management plans to propose a dividend of EUR 0.50 per share for the business year 2013 at the Annual General Meeting. For the full year 2014, LANXESS expects a slightly improved EBITDA pre exceptionals due alone to the absence of one-off items, even if selling prices remain at low levels. Cologne, February 26, 2014 Forward-Looking Statements. This news release may contain forward-looking statements based on current assumptions and forecasts made by LANXESS AG management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 26.02.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: LANXESS Aktiengesellschaft Kennedyplatz 1 50569 KÃ¶ln Germany Phone: +49 (0)221 8885-0 Fax: +49 (0)221 8885-4944 E-mail: ir@lanxess.com Internet: www.lanxess.com ISIN: DE0005470405 WKN: 547040 Indices: DAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, Hannover, MÃ¼nchen, Stuttgart; TerminbÃ¶rse EUREX End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Main Street Merger Faces Scrutiny: What It Means for Shareholders

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Investigation of Maplebear Sale to DoorDash Sparks Debate

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Greenberg Traurig's 93 Attorneys Shine on Super Lawyers List

A Legal Powerhouse Expands Its Reputation Just when you think you've got the legal market pegged, something like this pops up: Greenberg Traurig's 93 attorneys make it onto the coveted 2026 New York Metro Super Lawyers lists. We're talking about 59 making the 'Super Lawyers' list and 34 slipping into the 'Rising Stars' category. They even had Vice Chairman Robert J....

Nanoscope Therapeutics Aims for Eye-Catching Advances

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Sabey Data Centers Tests HVO to Cut Emissions

Exploring New Horizons in Data Center Energy A curious tale is unfolding down in Austin, Texas, folks—one where data centers meet renewable energy in a bid to clean up their act. Sabey Data Centers is giving good old-fashioned diesel the boot in favor of hydrotreated vegetable oil (HVO) for backup power. We're not talking about minor tweaks here; this is about testing...

Food Emulsifiers Surge: Market to Hit $5.60B by 2031

Forecasting Growth in Food Emulsifiers Picture this: the food emulsifiers market is steaming ahead, anticipating a thunderous boom from $4.43 billion in 2026 to a whopping $5.60 billion by 2031. According to recent estimates, that's a steady clip at a CAGR of 4.8%. If you're thinking that's just more industry chatter, let's peel back the layers and see what makes this...

Membrane Chromatography Market Surges with Biologics Boom

Another Chapter in Chromatography: What's New? It's like this: membrane chromatography is getting its day in the sun, and it's about time we dive into why it's happening. Projected to scale up from $0.37 billion in 2026 to a neat $0.63 billion by 2031, we’re talking a solid 11.3% compound annual growth rate. It's a tale of tech advancements and rising demand for...

transcosmos Boosts Supply Chain with AI-Powered Tools

No-Nonsense Supply Chain Evolution at transcosmos Take a hard look at the chaos flying around the supply chain arena these days. It's like every time you turn your head, there's a new twist landing folks into deeper complexity. Look, if you thought supply chain management was a snooze of a topic, think again because transcosmos just dialed up the intensity with its...

Co-op Giants Earn $309B: Key Players Spotlighted

Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...

European Doctors Explore Chinese Aesthetic Innovations

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...